Pen-Hua Su

5PUBLICATIONS
6CO-AUTHORS
Aboriginal and Torres Strait Islander theory of change models for healthPredictive and prognostic markersPharmacogenomicsMolecular targetsOptical technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 06, 2026
Comparative 24-month cardiovascular outcomes and biomarker trajectories with semaglutide, empagliflozin, and sitagliptin in people with obesity and type 2 diabetes: a multicenter real-world study.

|Jun 29, 2026
Neuropsychiatric association of tirzepatide and semaglutide in obesity with and without type 2 diabetes.

|Apr 17, 2026
Two-Year Biomarker Trends and Kidney/Mortality Outcomes After Semaglutide Versus Phentermine-Topiramate and Naltrexone-Bupropion in People With Obesity and Without Diabetes.

|Dec 12, 2025
Effectiveness of Pre-Transplant Dual GLP-1 Receptor Agonist and SGLT2 Inhibitor Therapy on All-Cause Mortality in Organ Transplantation Candidates with Obesity and Type 2 Diabetes: a Target-Trial Emulation.

Yu-Nan Huang, Min-Yu Tsou, Pin-Hung Li

|Aug 01, 2025
Comparative ocular outcomes of tirzepatide versus other anti-obesity medications in people with obesity.

Yu-Nan Huang, Jo-Ching Chen, Pin-Hung Li

Pageof 1

Frequent Collaborators

3 joint publications

Gideon Meyerowitz-Katz

3 joint publications

Yu-Nan Huang

2 joint publications

Jo-Ching Chen

1 joint publications

Pin-Hung Li